StonvexLoading…
StonvexStonvexStonvexCore line items from CMPR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $3.40B | $3.29B | $3.08B | $2.89B |
Operating Income | $226.27M | $247.35M | $57.31M | $47.30M |
Net Income | $14.95M | $173.68M | $-185.98M | $-54.33M |
EPS (Diluted) | $0.58 | $6.43 | $-7.08 | $-2.08 |
Total Assets | $1.97B | $1.89B | $1.85B | $2.17B |
Total Liabilities | $2.53B | $2.42B | $2.47B | $2.53B |
Cash & Equivalents | $233.98M | $203.78M | $130.31M | $277.05M |
Free Cash Flow OCF − CapEx | $209.05M | $295.80M | $76.52M | $165.50M |
Shares Outstanding | 24.48M | 25.08M | 26.34M | 26.11M |